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Abstract
Proteomics is inherently a systems science that studies not only measured protein and their 
expressions in a cell, but also the interplay of proteins, protein complexes, signaling pathways, and 
network modules. There is a rapid accumulation of Proteomics data in recent years. However, 
Proteomics data are highly variable, with results being sensitive to data preparation methods, 
sample condition, instrument types, and analytical method. To address this challenge in 
Proteomics data analysis, we review common approaches developed to incorporate biological 
function and network topological information. We categorize existing tools into four categories: 
tools with basic functional information and little topological features (e.g., GO category analysis), 
tools with rich functional information and little topological features (e.g., GSEA), tools with basic 
functional information and rich topological features (e.g., Cytoscape), and tools with rich 
functional information and rich topological features (e.g., PathwayExpress). We review the 
general application potential of these tools to Proteomics. In addition, we also review tools that 
can achieve automated learning of pathway modules and features, and tools that help perform 
integrated network visual analytics.
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1 Introduction
Proteomics, the collective study of all measured proteins in cells of a given condition, is 
inherently a systems science that requires the understanding of not only the independent 
parts—protein constituents and their expressions in a cell—but also the interplay of proteins, 
protein complexes, signaling pathways, and network modules as a whole for achieving 
biochemical functions. In 2001, Ideker et al. introduced an integrated approach to identify 
metabolic networks and build cellular pathway models, by using measurements from DNA 
microarrays, protein expressions, and protein interaction knowledge [1]. This work provides 
systems biology researchers with a practical example how biological networks could be used 
to perform integrative functional genomics data analysis. By gaining system-wide 
perspectives of protein functions, Proteomics promises to further study which subsets of 
proteins are essential in regulating specific biological process. In Proteomics analysis, the 
incorporating of prior knowledge how groups of proteins work in concert with each other or 
with other genes and metabolites has made it possible to unravel the complexity inherent in 
the analysis of cellular functions [2]. New network biology and systems biology techniques 
have emerged in recent Proteomics studies [3, 4] including cancer [5].
There has been a rapid accumulation of data due to advances in Proteomics technologies [2]. 
Proteomics data are often generated from high-throughput experimental platforms, e.g., two-
dimensional (2D) gel, liquid chromatography coupled tandem mass spectrometers (LC-MS/
MS), multiplexed immunoassays, and protein microarrays [6, 7]. These platforms can assay 
thousands of proteins simultaneously from complex biological samples [8] to measure the 
relative abundance of proteins or peptides in various biological conditions. More accurate 
quantitative measure of peptides could also be performed with isotopic labelling of proteins 
in two different samples [9]. Similar to Genomics, Proteomics studies have been widely 
used to extract functional and temporal signals identified in biological systems [10]. Popular 
experimental techniques to measure protein-protein interactions include the yeast two-hybrid 
(Y2H) system [11].
In contract to the recent accelerated application of next-generation sequencing (NGS) in 
biology, a primary hurdle that slows down Proteomics' applications is the Proteomics data's 
high variability, which makes it difficult to interpret Proteomics data analysis results 
biologically [12]. Possible sources of data variations arise from biological sample 
heterogeneity, sample preparation variance, protein separation variance, detection limits of 
various proteomics techniques, and pattern-matching peptide/protein identification or 
quantification inaccuracies from Proteomics data management software. The unusual high 
level of data noises inherent in Proteomics studies in contrast to those in DNA microarrays 
or NGS instruments have made Proteomics experiments difficult to repeat, and many 
statistical methods developed for Genomics applications ineffective. There are plenty of 
reviews that cover the computational challenges [13-15] and solutions to apply statistical 
machine learning approaches to the problem, e.g., with the use of support vector machines 
(SVM) [16], Markov clustering [17], ant colony optimization [18], and semi-supervised 
learning [19] techniques. The ultimate challenge, however, is how to extract functional and 
biological information from a long list of proteins identified or discovered from high-
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throughput Proteomic experiments, in order to provide biological insights into the 
underlying molecular mechanisms of different conditions [20]. Therefore, additional protein 
functional knowledge, e.g., the abundance of proteins, cellular locations, protein complexes, 
and gene/protein regulatory pathways, should be incorporated in the second phase of 
proteomics analysis in order to filter out noisy protein identifications missed in the first 
statistical analysis phase of Proteomics analysis.
Pathway and network analysis techniques can help address the challenge in interpreting 
Proteomics results. Analysis of proteomic data at the pathway level has become increasingly 
popular (Figure 1). For pathway analysis, we refer to data analysis that aims to identify 
activated pathways or pathway modules from functional proteomic data. Biological 
pathways can be viewed as signaling pathways, gene regulatory pathways, and metabolic 
pathways, all of which are curated carefully in reputable scientific publications. Pathway 
analysis can help organize a long list of proteins onto a short list of pathway knowledge 
maps, making it easy to interpret molecular mechanisms underlying these altered proteins or 
their expressions [20]. For network analysis, we refer to data analysis that build, overlay, 
visualize, and infer protein interaction networks from functional Proteomics and other 
systems biology data. Network analysis usually requires the use of graph theory, information 
theory, or Bayesian theory. Different from pathway analysis, network analysis aims to use 
comprehensive network wiring diagram derived both from prior experimental sources and 
new in silico prediction to gain systems-level biological meanings [21]. Many large 
knowledge bases on biological pathways and protein networks have been published, e.g., 
BioGRID [22], STRING [23], KEGG [24], Reactome [25], BioCarta [26], PID [27], HAPPI 
[28], HPD [29], and PAGED [30] databases.
Compared to pathway and network analysis approaches applied in genomics, the advantages 
of the related researches in proteomics are listed below: 1) Pathway analysis for proteomic 
data can be directly interpreted in signaling pathways with signal proteins. 2) Network 
analysis for proteomic data can have direct evidences supported by protein-protein 
interaction data validated by in-vitro experiments. 3)Both pathway analysis and network 
analysis for proteomic data can be visualized in a functional protein network with 
transcriptional factors labeled, which are all measured indirectly in genomic studies.
2 Pathway and Network Analysis for Proteomics
Many pathway databases and pathway analysis software tools have become available in the 
last decade [20, 31], with some directly applicable to Proteomics [5, 32]. In Proteomics, 
statistically significant proteins identified from high-throughput Proteomic instruments often 
suffer from high false discovery rate [13], partly because the inherently high level of 
variance in Proteomics data can make it difficult to identify true biological signals [14]. To 
assess the biological significance of Proteomics results, additional information such as Gene 
Ontology (GO) and pathways is needed. While there are numerous approaches to 
incorporate biological pathway and network data into Proteomics data analysis, we 
categorize existing approaches into two major characteristics, one focusing on integration of 
“functional information” and the other focusing on integration of “topological information”. 
For functional information, we refer to functional descriptions that aggregate genes into 
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common protein complexes, biological pathways, network modules, and other genes sets 
consisting of genes playing similar roles. For topological information, we refer to regulatory 
relationships that exist among genes, protein complexes, biological pathways, and biological 
network modules. In Figure 2, we organize the two independent characteristics as the x- and 
y- axis to categorize representative pathway and network analysis tools in a two-dimensional 
space. With this framework, we can further categorize existing pathway analysis tools into 
roughly four quadrants:
• Basic functional information and basic topological features (F-T-). An example is 
the uses of minimal additional information, e.g., GO categories, to interpret 
Proteomics results. Since the GO categories contain curated and known functions, 
and the interaction or regulation relationship information is not tested, the value for 
pathway and network analysis from the F-T- quadrant may be quite limited. We 
also consider the traditional feature selection method (e.g., linear programming 
based feature selection approach [33] or heterogeneous set identification [34]) in 
the F-T- quadrant, which is based on the classification algorithm and purely used 
the data itself. When facing simple problems that only require obtaining basic 
functional information from proteomic data, approaches in the F-T- quadrant will 
work very well.
• Basic functional information but rich topological features (F-T+). An example is 
the use of protein interaction or gene regulatory networks to help prioritize top-
ranked proteins retrieved from the Proteomics results. Since the protein-protein 
interaction or gene regulatory network contains the biological context, pathway and 
network analysis from the F-T+ quadrant can help reduce false discovery rate. A 
latest example is NOA (Network Ontology Analysis) [35]. If the applications are 
related to cascade regulation or signaling relationships, approaches from the F-T+ 
quadrant will be more suitable than the ones from the F-T- quadrant.
• Rich functional information but basic topological features (F+T-). An example is 
the use of gene set knowledge and corresponding knowledge to characterize 
significant biological phenomena that are strongly associated with Proteomics 
results. Since the gene set information— including both characterized and 
uncharacterized pathway-related gene sets—can be quite comprehensive, integrated 
Proteomics data analysis using computational techniques such as the GSEA 
analysis from the quadrant can reveal significant biological insights. If the 
applications are related to complex functional identification, especially for protein 
biomarker discovery, approaches from the quadrant will be more suitable than the 
ones from the F-T-quadrant.
• Rich functional information and rich topological features (F+T+). An example is 
the simultaneous use of both protein interaction/gene regulation information and 
curated gene set knowledge to build biological networks at different functional 
categorical levels (i.e., multiple biosystems scales). Since the multi-scale pathway 
interaction/regulation network can be complex, the F+T+ model can properly 
mimic the actual biological systems to provide the highest value to Proteomics 
researchers. Pathway-Express [36] is an exemplar tool showing how to move 
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toward this new quadrant. Once we meet problems related to both cascade 
regulation/signaling relationships and complex functional identification, especially 
for complex disease biomarker discovery, approaches shown in the F+T+ quadrant 
could be considered as our first options.
1) Pathway analysis using protein functional category information
Many pathway analysis tools in the F-T- or the F-T+ quadrant use basic functional 
information, since these tools focus on protein functional annotation or basic “functional 
enrichment analysis” among an unordered set of proteins identified from Proteomics data 
analysis [37]. These approaches aim to identify proteins with statistical significance first and 
functional significance subsequently. For example, GoMiner [38] can organize lists of 
“interesting” genes/proteins for biological interpretation in the context of GO terms, which 
is at the single-molecule level. DAVID [39] provides a comprehensive set of functional 
annotation tools which can not only identify enriched biological themes, particularly GO 
terms, but also discover enriched functionally-related gene groups and visualize genes/
proteins in pathway diagrams based on the famous pathway databases – KEGG [24] and 
BioCarta [26]. To provide broad pathway data coverage, the Human Pathway Database 
(HPD) [29] integrated KEGG [24], Reactome [25], BioCarta [26], and PID [27] databases 
ranges from molecular pathways to cellular pathways. The functional enrichment analysis of 
Proteomics results against these database resources is performed usually with an overlap 
cut-off score, e.g., as in the single enrichment analysis (SEA) [37]; therefore true signals that 
are marginally significant from statistical tests may be filtered out prematurely.
Pathway analysis tools moving from the F-T- quadrant to the quadrant is able to better 
integrate statistical significance from Proteomics data analysis into functional enrichment. 
Compared with SEA, gene set enrichment analysis (GSEA) [40] evaluates statistical 
significance of a ranked list of genes/proteins (i.e. gene sets) against one or more pathway 
data set. GSEA not only can detect group-wise statistically-significant genes and proteins, 
but also enriched pathway gene sets against a large database of gene sets previously 
characterized in functional genomic studies. To support GSEA, databases such as the 
Molecular Signature Database (MSigDB) [41], GeneSigDB [42], and PAGED [43] have 
been developed to integrate GO categories, pathways from KEGG [24], gene regulatory 
targets from TRANSFAC [44], micro-RNA targets, and curated gene sets that are co-
expression signatures from literature. GSEA and comprehensive databases populated 
pathway modules can help streamline statistical and functional determination of groups of 
proteins identified from generally “noisy” Proteomics results.
2) Pathway analysis using network topological information
Moving from the F-T- quadrant to the F-T+ quadrant, tools take a different strategy to 
perform pathway analysis, i.e., to treat pathways and pathway models as a form of network 
data structure from which one may incorporate network topological information into the 
Proteomic data analysis. Here, we refer to biological pathways and biological pathway 
models interchangeably. In practice, however, biological pathways refer to signaling 
pathways, gene regulatory networks and metabolic pathways [45], whereas biological 
pathway models refer to computer representation of actual biological events that have been 
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abstracted. Network representation of biological pathway models involve topologically 
connected molecules (e.g., genes, proteins, or metabolites) and molecular events (e.g., 
protein interactions, gene regulations, or metabolite reactions) that are carefully assembled 
into a graph. While there are 550 biological pathway data sources according to Pathguide 
(http://www.pathguide.org/), only approximately 10% of them provide pathway 
diagrammatic details suitable as pathway models; the remaining 90% may only be useful for 
functional category analysis described earlier. Cytoscape [46] is an open-source biological 
network analysis platform to visualize and analyze biological pathways based on network 
topological information. IPA from Ingenuity and MetaCore from GeneGo are commercially 
available to perform network and pathway analysis for manual pathway data analysis and 
modeling. However, manual examination of a given biological pathway structure is no 
longer scalable when it involves more than a few dozen nodes and several hundred edges in 
the network.
To address scalability issues, tools in the F-T+ quadrant must evaluate both statistical 
significance and topological significance with computational method. An example is 
Pathway-Express [36], which develops “impact analysis” techniques to prioritize 
biologically-significant genes/proteins with lower FDRs. Impact analysis measures network 
topological information as degree of connectivity and clustering coefficient and applies it as 
weight for given genes/proteins in the biological pathway to calculate an “impact factor” for 
the entire pathway. It further evaluates whether the impact factor obtained is significant due 
to a possible network perturbation event or a random chance. Separately, signaling pathway 
impact analysis (SPIA) combines both functional evidences from classical enrichment 
analysis and topological evidences represented as perturbation factor on a given pathway 
under a given condition [47]. Network analysis using partial network modules are also 
promising, e.g., developing pathway biomarkers from proteomic data [48] and breast cancer 
subtyping from plasma proteins [49]. In all, these pathway/network analysis tools integrates 
network topological information at a limited scale, either at the protein interaction network 
level or at the network module level.
3) Pathway analysis using a multi-scale hybrid strategy
To understand complex molecular mechanisms associated with a biological condition using 
Proteomics, a researcher must not only study specific proteins whose expressions are altered 
or specific pathways in which signaling cascades take place, but also understand how 
external and internal stimuli translates into coordinated changes of genes, proteins, 
metabolites, signaling network modules, pathways, and other functional components in a 
cell. This is why tools in the F+T+ quadrant must be developed. For example, the concept of 
“GO functional crosstalk network” was introduced in 2008, based on graph representations 
that use GO functional categories as nodes and enriched protein interactions between GO 
functional categories as edges [50]. In this work, researchers integrated network topological 
information and functional information together, resulting in enhanced characterization of 
complex ovarian cancer drug resistance development mechanism from Proteomics tandem 
mass spectrometry data. Similarly, pathway similarity networks can be built from 
heterogeneous pathway data as nodes and pathway-pathway similarity measurement as 
edges [29]. Pathway association networks (PAN) as a more special form of “GO functional 
Wu et al. Page 6
J Theor Biol. Author manuscript; available in PMC 2015 December 07.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
crosstalk networks” can be built from heterogeneous pathway data as nodes and significant 
protein-protein interaction enrichments as edges [51]. The concept of PANs have already 
been successfully applied into complex disease modeling for cancer progression [52], 
Alzheimer's disease [53], and colorectal cancer [54]. Recently, a comprehensive approach to 
construct multi-edge gene-set networks based on co-memberships, protein interactions, and 
co-enrichment has also been proposed [55].
Tools in the F+T+ quadrant can benefit significantly from knowledge bases that build 
relationships between different molecular biosystem components, e.g., pathways, disease-
associated gene sets, molecular signatures, microRNA and all their gene targets, and protein 
interaction network modules. Using molecular biosystem component similarity measures for 
human in PAGED, a PAN can be developed to serve as a system-level pathway model for 
interpretation of complex molecular profiling study results. In Figure 3, we demonstrate a 
workflow platform with which we apply multi-scale pathway analysis to the characterization 
of colorectal cancer MS-based proteomic data. The input LC-MS data comes from the 
cceHUB web portal (The Cancer Care Engineering project, hosted at https://ccehub.org/). 
This workflow utilizes both functional information from the PAGED [30] and topological 
information from the protein-protein interaction (PPI) database, such as HAPPI or STRING. 
The functional information validates Proteomics results obtained from LC-MS experiments 
of the colorectal cancer sample, while the final findings are subsequently examined in the 
integrated pathway model constructed from protein-protein interaction databases. In this 
study, we not only confirmed BRAF as a prognostic biomarker for colorectal cancer [56], 
but also discovered NNMT to be a potential biomarker worth experimental validations [57].
4) Automated learning of pathway modules and features
Functional and network information related to pathway models can be either extracted from 
large existing databases, or learned automatically from functional genomics and Proteomics 
data sets. There are two types of knowledge discovery tasks. The first is the discovery of 
pathway modules from pathway and network data relevant to Proteomics results. The second 
is the discovery of network topological features.
In the first type, “pathway module discovery”, one can assume that there is a close 
relationship between common protein function categories and proteins closely regulated in 
the same pathway or network [58]. Existing pathway knowledge or other functional 
information could also be used to validate newly-discovered pathway models or pathway 
modules. Hartwell et al. [59] define “network module” as an entity comprising of different 
types of interacting molecules with strong connections within each other but weak 
connections outside of the entity. Network modules may map to protein complexes or 
molecular pathways, consisting of a large number of molecules that co-regulate each other 
to perform particular cellular functions. Due to the difficulty by human curators to read 
hundreds of research articles and document molecular regulation details in biological 
networks, computerized techniques to identify network modules usually involve some form 
of automated graph clustering of the biological network data [60-62]
In the second type, “network feature discovery”, automated network-based learning of 
topological and functional information can be done with nonlinear dynamical modeling, 
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when there is no absolute rank for each protein as the node and no clear cluster network 
module boundaries in the network [63]. Hence, traditional network analysis approaches, 
such as node ranking and graph clustering, are not directly applicable [64]. The lack of 
absolute rank or cluster boundaries is characteristic of scale-free biological networks and is 
also common in other nonlinear systems such as fractals (multi-scale self-similarity), chaos, 
and phase transitions [65]. Nonlinear dynamical modeling approach, e.g., ant colony 
optimization (ACO) [66], has already been applied to the analysis Proteomic data in 2007 
[18]. An ACO-based network reordering (ACOR) algorithm has been show effective in 
analyzing complex networks to reveal fractal-like patterns in the studies of yeast lethal gene 
study [67], breast cancer [68], and Alzheimer's disease (AD) [69]. A recent study to classify 
AD and normal brain tissue samples showed that prediction based on the ACOR algorithm 
had better performance than even the best available approaches using either node ranking or 
graph clustering alone [70]. In contract, Proteomics biomarker results obtained from 
traditional network analysis approaches such as [71-73] reported that sometimes breast 
cancer metastasis predictions consisting of multiple genes cannot compete well in 
performance against optimized single-gene classifiers by comparison [74].
3 Network Analysis for Complex Protein Networks
Complex protein networks are often characterized by scale-free properties [63], i.e., their 
node distribution follow power laws. Such networks are highly robust to node 
communication errors, even with unrealistically high failure rates [75]. The ability of error 
tolerance not only appears in complex protein networks, but also has been found in many 
other types of scale-free networks, such as World-Wide Web (WWW), the Internet, social 
networks and cell networks [64]. This suggests that network modeling and analysis methods 
originally designed for complex social networks can be also applied to analyzing complex 
protein networks.
The motivation for network analysis specific for complex protein networks derives from 
complex disease (e.g. various cancers, Alzheimer's disease and type II diabetes etc.) network 
biomarker discovery, since there are thousands of genes/proteins respond to disease driving 
factors and drug sensitivity/resistance. As we all know, a complex disease is usually not one 
disease, but multiple subtypes of disease phenotypes. To discover hidden molecular 
mechanisms for early diagnosis, prognosis, and drug response, we have to deal with large-
scale disease-specific protein networks with hierarchical functional relationships under 
different conditions, in order to develop tailored therapies for different subtypes of patients, 
which is the main goal of personalized medicine. Here we will introduce several cutting-
edge works for modeling and analyzing large-scale complex protein networks, utilizing vast 
topological information and group functional information.
1) Network reordering using global topological information
A complex network with scale-free property may also have high-degree “inseparability”, 
which means that there is no “absolute rank” for each node or no “clear cluster” in the 
network. Hence, traditional network analysis approaches, such as node ranking and graph 
clustering, often failed when facing complex networks. Scale-free is an analogy to the 
situation where power laws arise and no single characteristic scale can be identified, which 
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also happens in other nonlinear phenomena, such as fractals (multi-scale self-similarity), 
chaos, and phase transitions [65]. Based on this connection, nonlinear dynamical modeling 
may have great potential in analyzing complex protein networks. As a typical nonlinear 
dynamical modeling approach, ant colony optimization (ACO) [66], which has been already 
applied to analyzing MS-based proteomic data in 2007 [18], can be also employed for 
complex protein network analysis. An ACO-based network reordering (ACOR) algorithm 
was developed in 2009 to analyze complex networks and the results revealed fractal-like 
patterns in protein interaction networks for yeast lethal gene study [67], breast cancer 
(BRCA) research [68], and Alzheimer's disease (AD) diagnosis [69] respectively. These 
interesting patterns might be closely related to scale-free properties.
Different with traditional network analysis approaches only using local topological 
information, the ACOR algorithm can efficiently extract global topological information in a 
complex network, through assigning each node an order number - “relative rank” in 
“overlapped clusters”. In a recent case study on microarray classification for brain tissue 
samples of AD patients vs. normal controls, prediction based on the ACOR algorithm 
showed better performance than the one using either node ranking or graph clustering [70]. 
Interestingly, the prediction power of these traditional network analysis approaches is only 
at the same level with the one using random-ordering but still keeping node degree values – 
typical local topological information. Another case study on breast cancer metastasis 
prediction also showed that several most popular pathway or network-based approaches 
[71-73] even cannot compete with a simple, single genes based classifier in an extensive and 
critical comparison [74]. In Figure 4, we showed an intuitional comparison of the results 
respectively produced by conventional network-based gene ranking (similar to PageRank 
algorithm used by Google) [76], 2D hierarchical clustering [77] and ACOR [67-69], for 
analyzing a BRCA-related protein interaction network [68]. From this comparison, we can 
see directly that only ACOR approach can reorder the adjacency matrix of the BRCA-
related protein network to a meaningful pattern, which has many clusters closely 
overlapped. All the evidences showed here directly point to an important conclusion – 
utilization of global topological information is the key of analyzing complex protein 
networks.
2) Visual analytics using both topological and functional information
A complex protein network usually consists of thousands proteins, which make the network 
layout looks like a messy hair ball on conventional network visualization platforms. An 
example of complex protein network visualization by Cytoscape can be seen in Figure 5. 
One way to overview complex networks is to visualize them at the functional level. A 
functional category crosstalk network was constructed based on protein interaction networks 
for ovarian cancer drug resistance study in 2007. This network was first shown as a matrix 
of interactions between related GO terms, also called GO-GO interactions [78], which took 
the advantages of both local topological information and group functional information. 
Another way to simplify complex network visualization is to use the concept of molecular 
network terrain. Molecular network terrain visualization grows from the work of Kim S.K., 
et al. in 2001 [79], who assembled data from C. Elegans DNA microarray experiments, and 
visualized grouped co-regulated genes in a three-dimensional (3D) expression map that 
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displays correlations of gene expression profiles as distances in two dimensions and gene 
density in the third dimension. In a subsequent study, You, Q., et al. visualized an 
Alzheimer's disease (AD) specific protein interaction network as a 3D terrain, and 
successfully differentiated the three distinct stages of AD [80]. The visual analytics 
approach based on molecular network terrains could increase accuracy and noise endurance 
for sample molecular classifications, by utilizing both global topological information and 
group functional information.
As shown in Figure 5, the terrain-based classification approach exhibited amazing 
performance in a case study on prostate cancer (PC) microarray classification between 
primary prostate tumor (PT) samples and metastatic (MT) samples. We randomly selected 
24 gene expression profiles (12 PT samples and 12 MT samples) from a microarray dataset 
(GSE6919 [81, 82]) in GEO. We only used 4 PT samples and 4 MT samples as training set, 
and used the left 16 samples as testing set. Although all the terrain images here look like the 
same, they can be easily distinguished by computer program. We applied a terrain model, 
derived from a PC-specific protein interaction network containing 2637 proteins and 5772 
interactions (also shown in figure 5), and simply used the distance between a testing terrain 
image and average terrain image to determine its group for two-group classification. 
Although these metastatic samples derive from different organs, and are highly 
heterogeneous in expression, the left 8 MT samples are all correctly classified (100%), and 
the left 7 of 8 PT samples are also correctly classified (87.5%), which makes the total 
accuracy reach 93.75%. Moreover, as clearly shown in Figure 5, the differential terrain 
image between two groups identified a crucial gene clusters, including androgen receptor 
(ANDR) and early growth response protein (EGR1), which are all well-known, and have 
been validated to be closely related to PC metastasis previously [82]. This case study 
demonstrates again the power of using global topological information. Furthermore, it shows 
that utilization of group functional information (from network modules) not only can be an 
important supplement to pathway analysis, but also brings great convenience to the 
interpretation for complex network analysis.
4 Summary
Due to the data variability issues inherent in Proteomics measurements, statistical 
significance alone is insufficient to the evaluation of Proteomics results. We believe both 
pathway models' functional information and topological information should be integrated to 
make Proteomics data interpretation relevant to biological mechanism. With the availability 
of two types of information, one in protein functional categories and the other in network 
topological features, we can categorize pathway analysis tools available to Proteomics 
researchers today as falling into any one of the 2 × 2 quadrants as described in this review. 
GSEA enables molecular signature-based statistical significance testing, which integrates 
protein functional category information effectively with statistical testing of functional 
genomics or Proteomics results. Cytoscape enables network-based data analysis of 
biological data in situations where functional information may or may not be available. 
SPIA enables pathway-based statistical assessment by combining both functional annotation 
and local topological annotation of the network. Ultimately, future tools must support 
elucidation of complex molecular mechanisms suggested from Proteomics results from 
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multi-scale network data and molecular signature data. A workflow with a hybrid strategy 
for multi-scale pathway analysis of LC-MS proteomic data was presented. New tools to 
extract and integrate gene set knowledge from public databases using PAGED and ACOR 
can be promising. Ultimately, the use of terrain-based visual analytics can be more fruitful, 
because it gives users inexperienced with network biology or systems biology analysis a rich 
user experience based on a visualization interface. However, there are still significant 
challenges in designing next-generation network/pathway analysis tools. In large complex 
gene regulatory networks and pathway association networks, network coverage can be poor. 
Accurate protein or protein group functional information at each network scale may be 
missing. Proposed findings of molecular mechanisms at the network module level can also 
be more challenging to validate experimentally than at the individual protein level. 
Nonetheless, the opportunity to discover novel complex mechanisms of biological processes 
will keep researchers in the field occupied for quite some time.
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Figure 1. 
Trends of pathway and network analysis in Proteomics from decade publications (searched 
in Google Scholar with terms of [“pathway analysis” AND “Proteomics”], and [“network 
analysis” AND “Proteomics”]).
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Figure 2. 
Conceptual plot of different pathway analysis tools according to the utilization of functional 
information and/or topological information (positions are NOT absolute).
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Figure 3. 
Illustration of multi-scale pathway analysis using colorectal cancer proteomic data as an 
example. The protein-protein interaction (PPI) database for the Step 8) could use STRING 
or HAPPI.
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Figure 4. 
Re-ordered network adjacency matrices of a weighted BRCA-related protein interaction 
network with 1035 proteins and 1582 interaction, expanded in HAPPI from 223 breast 
cancer associated genes from OMIM. (A) The result ranked by GeneRank (similar to 
PageRank algorithm used by Google), (B) The result clustered by 2D hierarchical clustering 
in Matlab Bioinformatics Toolbox, and (C) The result reordered by Ant Colony 
Optimization Reordering (ACOR) algorithm. (CS: confidence score for protein interaction 
in the HAPPI database)
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Figure 5. 
Prostate cancer microarray classification between primary prostate tumor (PT) samples and 
metastatic (MT) samples by using terrain-based visual analytics approach. The terrain model 
derived from a PC-specific protein interaction network containing 2637 proteins and 5772 
interactions. 24 gene expression profiles (12 PT samples and 12 MT samples) are randomly 
selected from a microarray dataset GSE6919 in GEO. The only one PT sample classified 
incorrectly is marked.
Wu et al. Page 20
J Theor Biol. Author manuscript; available in PMC 2015 December 07.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Wu et al. Page 21
Ta
bl
e 
1
Se
le
ct
ed
 p
at
hw
ay
/n
et
w
or
k 
an
al
ys
is 
re
so
ur
ce
 th
at
 c
an
 b
en
ef
it 
Pr
ot
eo
m
ic
s d
at
a 
an
al
ys
is.
N
am
e
D
es
cr
ip
tio
n
Li
nk
R
ef
er
en
ce
Fu
nc
tio
na
l I
nf
o 
U
sin
g
To
po
lo
gi
ca
l I
nf
o 
U
sin
g
G
oM
in
er
G
en
e 
O
nt
ol
og
y 
(G
O)
 an
aly
sis
 fo
r O
mi
c 
da
ta
ht
tp
://
di
sc
ov
er
.n
ci
.n
ih
.g
ov
/g
om
in
er
/
[3
8]
Si
ng
le
 m
ol
ec
ul
e
N
on
K
EG
G
K
yo
to
 E
nc
yc
lo
pe
di
a 
of
 G
en
es
 a
nd
 
G
en
om
es
ht
tp
://
w
w
w
.g
en
om
e.
jp/
ke
gg
/
[2
4]
M
ol
ec
ul
ar
 p
at
hw
ay
N
on
D
A
V
ID
Th
e 
D
at
ab
as
e 
fo
r A
nn
ot
at
io
n,
 
V
isu
al
iz
at
io
n 
an
d 
In
te
gr
at
ed
 D
isc
ov
er
y
ht
tp
://
da
vi
d.
ab
cc
.n
ci
fc
rf.
go
v/
[3
9]
M
ol
ec
ul
ar
 p
at
hw
ay
Sm
al
l-s
ca
le
PI
D
Pa
th
w
ay
 In
te
ra
ct
io
n 
D
at
ab
as
e
ht
tp
://
pi
d.
nc
i.n
ih
.g
ov
/
[2
7]
Ce
llu
la
r p
at
hw
ay
N
on
H
PD
H
um
an
 P
at
hw
ay
 D
at
ab
as
e
ht
tp
://
bi
o.
in
fo
rm
at
ic
s.i
up
ui
.e
du
/H
PD
[2
9]
Ce
llu
la
r p
at
hw
ay
Sm
al
l-s
ca
le
G
ES
A
G
en
e 
Se
t E
nr
ic
hm
en
t A
na
ly
sis
ht
tp
://
w
w
w
.b
ro
ad
in
sti
tu
te
.o
rg
/g
se
a/
[4
0]
Ce
llu
la
r p
at
hw
ay
Sm
al
l-s
ca
le
IP
A
In
ge
nu
ity
 p
at
hw
ay
 a
na
ly
sis
ht
tp
://
w
w
w
.in
ge
nu
ity
.c
om
/
N
/A
M
ol
ec
ul
ar
 p
at
hw
ay
Sm
al
l-s
ca
le
M
et
aC
or
e
Th
om
so
n 
Re
ut
er
s p
at
hw
ay
 a
na
ly
sis
 a
nd
 
kn
ow
le
dg
e 
m
in
in
g
ht
tp
://
th
om
so
nr
eu
te
rs
.c
om
/m
et
ac
or
e/
N
/A
Ce
llu
la
r p
at
hw
ay
Sm
al
l-s
ca
le
Pa
th
w
ay
-E
xp
re
ss
A
 sy
ste
m
s b
io
lo
gy
 a
pp
ro
ac
h 
fo
r p
at
hw
ay
 
le
ve
l i
m
pa
ct
 a
na
ly
sis
ht
tp
://
vo
rte
x.
cs
.w
ay
ne
.e
du
/p
ro
jec
ts.
htm
[3
6]
M
ol
ec
ul
ar
 p
at
hw
ay
M
id
-S
ca
le
SP
IA
Si
gn
al
in
g 
Pa
th
w
ay
 Im
pa
ct
 A
na
ly
sis
ht
tp
://
w
w
w
.b
io
co
nd
uc
to
r.o
rg
/p
ac
ka
ge
s/2
.1
2/
bi
oc
/h
tm
l/S
PI
A
.h
tm
l
[4
7]
M
ol
ec
ul
ar
 p
at
hw
ay
M
id
-S
ca
le
PA
G
ED
A
n 
in
te
gr
at
ed
 P
at
hw
ay
 A
nd
 G
en
e 
En
ric
hm
en
t D
at
ab
as
e
ht
tp
://
bi
o.
in
fo
rm
at
ic
s.i
up
ui
.e
du
/P
A
G
ED
[3
0]
Sy
ste
m
 p
at
hw
ay
M
id
-S
ca
le
H
A
PP
I
H
um
an
 A
nn
ot
at
ed
 a
nd
 P
re
di
ct
ed
 P
ro
te
in
 
In
te
ra
ct
io
n 
da
ta
ba
se
ht
tp
://
bi
o.
in
fo
rm
at
ic
s.i
up
ui
.e
du
/H
A
PP
I
[2
8]
Si
ng
le
 m
ol
ec
ul
e
La
rg
e-
sc
al
e
ST
RI
N
G
Se
ar
ch
 T
oo
l f
or
 th
e 
Re
tri
ev
al
 o
f 
In
te
ra
ct
in
g 
G
en
es
/P
ro
te
in
s
ht
tp
://
str
in
g.
em
bl
.d
e/
[2
3]
Si
ng
le
 m
ol
ec
ul
e
La
rg
e-
sc
al
e
Cy
to
Sc
ap
e
A
n 
op
en
 so
ur
ce
 p
la
tfo
rm
 fo
r c
om
pl
ex
 
n
et
w
or
k 
an
al
ys
is 
an
d 
vi
su
al
iz
at
io
n
ht
tp
://
w
w
w
.c
yt
os
ca
pe
.o
rg
/
[4
6]
M
ol
ec
ul
ar
 p
at
hw
ay
La
rg
e-
sc
al
e
A
CO
R
A
nt
 C
ol
on
y 
O
pt
im
iz
at
io
n 
Re
or
de
rin
g
N
/A
[6
7-
70
]
M
ol
ec
ul
ar
 p
at
hw
ay
La
rg
e-
sc
al
e
G
en
e-
Te
rra
in
Te
rr
ai
n-
ba
se
d 
vi
su
al
 a
na
ly
sis
 fo
r c
om
pl
ex
 
n
et
w
or
ks
N
/A
[7
9]
, [
80
]
N
et
w
or
k 
m
od
ul
e
La
rg
e-
sc
al
e
J Theor Biol. Author manuscript; available in PMC 2015 December 07.
